文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

血小板输注阈值对脓毒症患者结局的影响:MIMIC-IV数据库分析

Impact of Platelet Transfusion Thresholds on Outcomes of Patients With Sepsis: Analysis of the MIMIC-IV Database.
PubMed 文献 · Shock · 2022-01-01
一句话结论在脓毒症合并血小板减少患者中,较高阈值(20,000-50,000/μL)输注血小板与较低阈值(低于20,000/μL)相比,28天和90天死亡率更低。

本研究为回顾性队列研究,从MIMIC-IV数据库提取ICU脓毒症并接受血小板输注的患者数据,按输注前血小板计数分为低阈值组(低于20,000/μL,76例)和高阈值组(20,000-50,000/μL,217例)。高阈值组28天和90天死亡率分别为43.3%和60.8%,低阈值组分别为67.1%和82.9%,调整后OR分别为1.96(95%CI 1.16-3.03,P=0.012)和2.04(95%CI 1.16-3.57,P=0.012),均支持高阈值组死亡率更低。两组红细胞输注、无ICU天数和无住院天数无差异。亚组分析显示高阈值获益趋势一致,但仅在低风险组达到统计学显著。E值分析提示对未测量混杂稳健。

要点

  • 高阈值组(20,000-50,000/μL)28天死亡率43.3%(94/217),低阈值组(低于20,000/μL)67.1%(51/76),调整OR 1.96(95%CI 1.16-3.03,P=0.012)。
  • 高阈值组90天死亡率60.8%(132/217),低阈值组82.9%(63/76),调整OR 2.04(95%CI 1.16-3.57,P=0.012)。
  • 两组红细胞输注、无ICU天数、无住院天数无差异。
  • 按死亡风险分层后,高阈值获益趋势一致,但仅在低风险组达到统计学显著。
  • E值分析提示结果对未测量混杂稳健。

适用人群与场景

  • 纳入:ICU脓毒症并接受血小板输注、合并血小板减少的患者,数据来自MIMIC-IV数据库。

诊断标准与关键阈值

  • 按输注前血小板计数计算阈值,分为低阈值组(低于20,000/μL)和高阈值组(20,000-50,000/μL)。

研究设计与关键结果

  • 回顾性队列研究,从MIMIC-IV数据库提取数据,低阈值组76例,高阈值组217例。
  • 高阈值组外科ICU入住率35.0% vs 低阈值组9.2%,qSOFA评分较低阈值组低。
  • 28天死亡率:高阈值组43.3%(94/217) vs 低阈值组67.1%(51/76),调整OR 1.96(95%CI 1.16-3.03,P=0.012)。
  • 90天死亡率:高阈值组60.8%(132/217) vs 低阈值组82.9%(63/76),调整OR 2.04(95%CI 1.16-3.57,P=0.012)。
  • 红细胞输注、无ICU天数、无住院天数两组无差异。
  • 按死亡风险分层亚组分析:高阈值获益趋势一致,仅在低风险组达到统计学显著。
  • E值分析提示对未测量混杂稳健。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于MIMIC-IV数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在脓毒症合并血小板减少患者中,较高阈值血小板输注与较低阈值相比,28天和90天死亡率降低更明显。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The benefits of platelet thresholds for transfusion remain unclear. This study assessed the effect of two transfusion thresholds on the survival outcomes of patients with sepsis and thrombocytopenia.

METHODS: In this retrospective cohort study, data of patients with sepsis admitted to an intensive care unit (ICU) and who had received platelet transfusion were extracted from the Medical Information Mart for Intensive Care IV database. Patients were classified into the lower-threshold group (below 20,000/μL) and higher-threshold group (20,000-50,000/μL), based on thresholds calculated from their pretransfusion platelet count. The endpoints included 28- and 90-day mortality, red blood cell (RBC) transfusion, ICU-free days, and hospital-free days.

RESULTS: There were 76 and 217 patients in the lower-threshold and higher-threshold groups, respectively. The higher-threshold group had a higher rate of surgical ICU admission (35.0% vs. 9.2%) and lower quick Sequential Organ Failure Assessment (qSOFA) score than the lower-threshold group. In the higher-threshold group, 94 (43.3%) and 132 (60.8%) patients died within 28 and 90 days, compared to 51 (67.1%) and 63 (82.9%) patients in the lower-threshold group (adjusted odds ratio, 1.96; 95% confidence interval, 1.16 to 3.03; P = 0.012; adjusted odds ratio, 2.04; 95% confidence interval, 1.16 to 3.57; P = 0.012, respectively). After stratification by mortality risk, the subgroup analysis showed a consistent trend favoring higher-threshold transfusion but reached statistical significance only in the low-risk group. There were no differences in red blood cell transfusion, ICU-free days, and hospital-free days between the groups. The E-value analysis suggested robustness to unmeasured confounding.

CONCLUSIONS: In patients with sepsis and thrombocytopenia, platelet transfusion at a higher threshold was associated with a greater reduction in the 28- and 90-day mortalities than that at a lower threshold.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhou W, Fan C, He S, et al. Impact of Platelet Transfusion Thresholds on Outcomes of Patients With Sepsis: Analysis of the MIMIC-IV Database. Shock. 2022. PMID: 34966069. doi:10.1097/SHK.0000000000001898

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。